Yong Hong International Biotechnology Co., Ltd. Announces Q1 2026 EPS of NT$0.60
NQ Score
0/100
N1 Content Completeness
0.8
AI Summary (NQ-processed)
Yong Hong International Biotechnology (6936) reported Q1 2026 earnings per share of NT$0.60, with operating revenue at NT$0.368 billion and net profit after tax at NT$0.044 billion. This financial disclosure is significant for investors in the biotechnology and medical industry.